SynthesisBreast (Edinburgh, Scotland)2026

Tucatinib in patients with HER2-positive advanced/metastatic breast cancer: A systematic literature review of real-world evidence.

Rodrigo Sanchez-Bayona et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.